Semaglutide and Tirzepatide enhance GLP- 1 and GIP hormones, regulating appetite, perfecting insulin perceptivity, and decelerating gastric evacuating to reduce jones and increase wholeness GLP- 1 and GIP hormones play pivotal places in appetite regulation, enhancing insulin perceptivity, and decelerating gastric evacuating to promote weight loss
GLP-1 medications are peptide-based, which means theyre especially sensitive to air, light, and temperature changes
10.1111/dom.15972 33 JiL.JiangH.ChengZ.QiuW.LiaoL.ZhangY.et al (2023)
Keep tablets in their original blister packaging until use
[4] The FDA label also provides guidance on when to consider discontinuation: if a patient has not lost at least 5% of their initial body weight after 12 weeks on the 2.4 mg dose, stopping treatment may be appropriate as further benefits are unlikely